135 related articles for article (PubMed ID: 2182413)
1. Therapy of childhood acute myelogenous leukemia: an update of the AIEOP/LAM 8204 study. Italian Pediatric Hematology-Oncology Association.
Amadori S; Ceci A; Comelli A; Madon E; Masera G; Nespoli L; Paolucci G; Zanesco L; Vegna ML; Moleti ML
Haematol Blood Transfus; 1990; 33():222-5. PubMed ID: 2182413
[No Abstract] [Full Text] [Related]
2. Intensive sequential chemotherapy for children with acute myelogenous leukemia.
Grier HE; Gelber RD; Clavell LA; Camitta BM; Link MP; Garcea MJ; Weinstein HJ
Haematol Blood Transfus; 1990; 33():193-7. PubMed ID: 2182411
[No Abstract] [Full Text] [Related]
3. Therapy of childhood acute nonlymphocytic leukemia: the Pediatric Oncology Group experience (1977-1988).
Steuber CP; Culbert SJ; Ravindranath Y; Krischer J; Ragab A; Civin C; Inoue S; Ruymann F; Leventhal B; Wilkinson R
Haematol Blood Transfus; 1990; 33():198-209. PubMed ID: 2182412
[No Abstract] [Full Text] [Related]
4. High-dose Ara-C as a single-agent consolidation therapy in childhood acute myelogenous leukemia.
Lie SO; Berglund G; Gustafsson G; Jonmundsson G; Siimes M; Yssing M
Haematol Blood Transfus; 1990; 33():215-21. PubMed ID: 2138994
[No Abstract] [Full Text] [Related]
5. Treatment of childhood acute nonlymphocytic leukemia: cooperative Austrian-Hungarian study AML-IGCI-84.
Fink FM; Gadner H; Grümayer ER; Kardos G; Revesz T; Urban C; Mutz I; Ausserer B; Schuler D
Haematol Blood Transfus; 1990; 33():233-6. PubMed ID: 2182415
[No Abstract] [Full Text] [Related]
6. Results of the Italian AIEOP/LAM 8204 study for the treatment of childhood AML: an update.
Amadori S; Mandelli F; Ceci A; Comelli A; Madon E; Masera G; Nespoli L; Paolucci G; Zanesco L; Defazio D
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():114-5. PubMed ID: 2653484
[No Abstract] [Full Text] [Related]
7. Consolidation therapy with high-dose cytosine arabinoside: experiences of a prospective study in acute myeloid leukemia.
Kurrle E; Ehninger G; Fackler-Schwalbe E; Freund M; Heil G; Hoelzer D; Link H; Löffler B; Lösch A; Mitrou PS
Haematol Blood Transfus; 1990; 33():254-60. PubMed ID: 2182418
[No Abstract] [Full Text] [Related]
8. Intensive induction therapy with behenoyl, cytosine arabinoside, daunorubicin, and 6-mercaptopurine followed by intensive consolidation with mitoxantrone, etoposide, vincristine, and intermediate-dose continuous cytarabine (M-85 protocol) for adult acute myelogenous leukemia.
Ohno R; Yokomaku S; Okumara M; Tanimoto M; Morishita Y; Morishima Y; Kodera Y; Saito H
Haematol Blood Transfus; 1990; 33():304-8. PubMed ID: 2182424
[No Abstract] [Full Text] [Related]
9. Acute nonlymphocytic leukemia in adults: results obtained with TAD remission induction therapy.
Witteveen EO; Verdonck LF; Nieuwenhuis HK; Dekker AW
Haematol Blood Transfus; 1990; 33():309-13. PubMed ID: 2323635
[No Abstract] [Full Text] [Related]
10. Mitoxantrone and etoposide in patients with relapsed and refractory acute nonlymphocytic leukemia.
Rowe JM; Mazza JJ; Hines JD; Cassileth PA; Oken MM; Bennett JM; Andersen J
Haematol Blood Transfus; 1990; 33():326-9. PubMed ID: 2182427
[No Abstract] [Full Text] [Related]
11. Predictive models for achievement of complete remission and duration of first remission in adult acute myeloid leukemia.
Heinecke A; Sauerland MC; Büchner T
Haematol Blood Transfus; 1990; 33():285-9. PubMed ID: 2182422
[TBL] [Abstract][Full Text] [Related]
12. Therapy of acute myelogenous leukemia in adults.
Petti MC; Broccia G; Caronia F; Di Raimondo F; Fioritoni G; Ladogana S; Leone G; Liso V; Musso M; Neri A
Haematol Blood Transfus; 1990; 33():249-53. PubMed ID: 2182417
[No Abstract] [Full Text] [Related]
13. Sequential decision strategy of the AML Cooperative Group studies.
Heinecke A; Sauerland MC; Büchner T
Haematol Blood Transfus; 1990; 33():290-4. PubMed ID: 2182423
[TBL] [Abstract][Full Text] [Related]
14. [Childhood acute myeloblastic leukemias. Report of 21 cases].
Laatiri MA; Chehata S; Amouri A; Bouaouina N; Chatti S; Saad A; Ennabli S
Tunis Med; 2000 Mar; 78(3):167-71. PubMed ID: 11026819
[TBL] [Abstract][Full Text] [Related]
15. Treatment of acute myelogenous leukemia in children: results of the Italian Cooperative Study AIEOP/LAM 8204.
Amadori S; Ceci A; Comelli A; Madon E; Masera G; Nespoli L; Paolucci G; Zanesco L; Covelli A; Mandelli F
J Clin Oncol; 1987 Sep; 5(9):1356-63. PubMed ID: 3476689
[TBL] [Abstract][Full Text] [Related]
16. Adult AML: the role of chemotherapy intensity and duration. Two studies of the AML Cooperative Group.
Büchner T; Hiddemann W; Blasius S; Koch P; Maschmeyer G; Tirier C; Sodomann H; Kuse R; Thiel E; Ludwig WD
Haematol Blood Transfus; 1990; 33():261-6. PubMed ID: 2182419
[No Abstract] [Full Text] [Related]
17. Combination of mitoxantrone and etoposide in patients aged over 60 years with untreated acute myelogenous leukemia.
Ehninger G; Fackler-Schwalbe E; Freund M; Heil G; Henke M; Hoelzer D; Hoffmann R; Kurrle E; Link H; Lösch A
Haematol Blood Transfus; 1990; 33():316-7. PubMed ID: 2182425
[No Abstract] [Full Text] [Related]
18. A randomized comparison of intensive maintenance treatment for adult acute myelogenous leukemia using either cyclic alternating drugs or repeated courses of the induction-type chemotherapy: AML-6 trial of the EORTC Leukemia Cooperative Group.
Jehn U; Zittoun R; Suciu S; Fiere D; Haanen C; Peetermans M; Löwenberg B; Willemze R; Solbu G; Stryckmans P
Haematol Blood Transfus; 1990; 33():277-84. PubMed ID: 1691132
[TBL] [Abstract][Full Text] [Related]
19. Proposal for the classification of relapsed and refractory acute myeloid leukemias as the basis for an age-adjusted randomized comparison of sequentially applied high-dose versus intermediate-dose cytosine arabinoside in combination with mitoxantrone (S-HAM).
Hiddemann W; Aul HC; Maschmeyer G; Urbanitz D; Lathan B; Reichle A; Köppler H; Donhuijsen-Ant R; Ludwig WD; Grüneisen T
Haematol Blood Transfus; 1990; 33():604-10. PubMed ID: 2182450
[No Abstract] [Full Text] [Related]
20. Improved treatment results in the myelocytic subtypes FAB M1-M4 but not in FAB M5 after intensification of induction therapy: results of the German childhood AML studies BFM-78 and BFM-83.
Ritter J; Creutzig U; Schellong G
Haematol Blood Transfus; 1990; 33():185-92. PubMed ID: 2182410
[No Abstract] [Full Text] [Related]
[Next] [New Search]
